Daniel Biasemcinally
Chief Financial Officer at Nucleus Network | Melbourne, Victoria, Australia
Daniel Biasemcinally’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Daniel Biasemcinally operates as the Chief Financial Officer at Nucleus Network, a Melbourne-focused entity in the hospital and health care sector that manages early phase clinical trials across Australia, the United States, and the United Kingdom. An alumnus of Queensland University of Technology, he combines private equity portfolio leadership with company directorship responsibilities to oversee financial strategy and operational execution. His tenure aligns with the firm’s established record of delivering over 2,500 early phase studies and 1,500 first-in-human trials across three major regulatory markets.
BEST APPROACH TO REACH Daniel Biasemcinally
Leverage his strong personal data footprint by reaching out through direct phone or personal email with a targeted proposal focused on optimizing treasury management and capital efficiency for complex global trial networks.
Chief Financial Officer at Nucleus Network in October 2022 - Present
Senior Associate at Blackstone in January 2019 - October 2022
Assistant Vice President at GE Capital in September 2016 - December 2018
Corporate Finance M&A Associate at GE Capital in January 2015 - August 2016
Financial Management Program at GE in January 2013 - January 2015
Business Analyst at FTI Consulting in February 2012 - November 2012
Summer Intern, Wealth Management at Commonwealth Bank in December 2011 - February 2012
QUT (Queensland University of Technology), Bachelor of Business with Honours, August 2026
Nucleus Network is the only global provider dedicated to early phase clinical trials, with units in Australia, the USA and the UK. Our unified network provides sponsors access to all three major regulatory markets through one trusted partner. With more than 2,500 early phase studies and 1,500 First in Human trials over 30 years, we are the most experienced early phase team worldwide. We are recognised for managing complex and adaptive designs with confidence, supported by proven scientific leadership and operational delivery. Alongside First in Human expertise, we conduct the full spectrum of clinical pharmacology studies, giving sponsors the depth, consistency and participant access to accelerate new medicines. One Network. Multiple Pathways. The Power of a Unified Global Network.
Discover more about Nucleus Network
Senior Business Development Director @ Nucleus Network | Strategic Partnerships, Business Development
We specialize in providing an extensive array of services tailored to support Biotechs, Pharmas, CROs and Clinical Trials Services Companies. Our offerings encompass:
Market Intelligence & Strategic Planning: Gain a competitive edge with our comprehensive market intelligence,...
Medical Officer
As a Medical Officer at Nucleus Network, I work primarily on Phase I clinical trials, contributing to early-stage drug development and translational research. My role involves:
• Conducting thorough medical screening and eligibility assessments for healthy volunteers and pa...
Sr. Director, Business Development
Nucleus Network is the world's only Phase 1 specialist with facilities in Australia and the USA.
For over two decades, Nucleus Network has been conducting Phase 1 clinical trials for Biotechnology and Pharmaceutical companies from across the globe. Recognized as Phase 1 clin...
Global CEO
Chief Executive Officer at Nucleus Network
(Jun 2023 – Present)
Masters of Biotechnology Research Extensive @ UQ| Scientist | Quality Control & Molecular Diagnostics | cGMP | Biopharmaceuticals | Research & Development | Leadership & Strategy | Administration
Data management, accurate transcription of clinical trial data from source documentation into CRFs and electronic data capture systems within sponsor-defined timelines, ensuring compliance with HREC-approved protocols, ICH-GCP (E6 R2), Nucleus Network SOPs, and ALCOA++ data in...
Phase I center in AUS and US for China clients.
Largest Phase I center in AUS. The only Phase I center with sites in the US, AUS and London.
What is Daniel Biase-mcinally email address?
Email Daniel Biase-mcinally at [email protected] and [email protected]. This email is the most updated Daniel Biase-mcinally's email found in 2026.
What is Daniel Biase-mcinally phone number?
Daniel Biase-mcinally phone number is +61431110920.
How to contact Daniel Biase-mcinally?
To contact Daniel Biase-mcinally send an email to [email protected] or [email protected]. If you want to call Daniel Biase-mcinally try calling on +61431110920. (updated on July 2026)
What company does Daniel Biasemcinally work for?
Daniel Biasemcinally works for Nucleus Network.
What is Daniel Biasemcinally's role at Nucleus Network?
Daniel Biasemcinally is Chief Financial Officer
What industry does Daniel Biasemcinally work in?
Daniel Biasemcinally works in the Hospital & Health Care industry.
